Pyxis Oncology
PYXS54
$3.500.00%$0.00
Penny Stock
PYXS54
$3.50
0.00%Performance History
| Key Stats | |
|---|---|
| Open | $3.51 |
| Prev. Close | $3.50 |
| EPS | -1.27 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $206.88M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 3.38 | 3.55 |
| 52 Week Range | 1.35 | 6.85 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -1.27 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Pyxis Oncology (PYXS)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Lara S. Sullivan M.D., MBA
- Headquarters
- Cambridge
- Employees
- 72
- Exchange
- NASDAQ
Keep an eye on Pyxis Oncology
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Pyxis Oncology's (PYXS) price per share?
The current price per share for Pyxis Oncology (PYXS) is $3.5. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Pyxis Oncology (PYXS)?
For Pyxis Oncology (PYXS), the 52-week high is $6.85, which is 95.71% from the current price. The 52-week low is $1.35, the current price is 159.26% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Pyxis Oncology (PYXS) a growth stock?
Pyxis Oncology (PYXS) has shown an average price growth of 0.41% over the past three years. It has received a score of 85 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pyxis Oncology as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Pyxis Oncology (PYXS) stock price performance year to date (YTD)?
As of the latest data, Pyxis Oncology (PYXS) has a year-to-date price change of 69.9%. Over the past month, the stock has experienced a price change of 3.86%. Over the last three months, the change has been -1.13%. Over the past six months, the figure is -44.27%.
help
Is Pyxis Oncology (PYXS) a profitable company?
Pyxis Oncology (PYXS) has a net income of -$73.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -409.25% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$82.2M. Furthermore, the EBITDA is -$63.16M.
help
What is the market capitalization of Pyxis Oncology (PYXS)?
Pyxis Oncology (PYXS) has a market capitalization of $206.3M. The average daily trading volume is 317.97K, indicating the stock's liquidity and investor engagement.
News
PRODUCT / SERVICES ANNOUNCEMENT
CHANGES IN SHARE CAPITAL AND VOTES
6/28/2024Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DIRECTORS AND OFFICERS
6/10/2024Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
CALENDAR OF EVENTS
CONFERENCE CALLS/ WEBCASTS
5/30/2024Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
5/14/2024
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
4/12/2024
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect?
NEWS
PENNY STOCKS
SMALL CAP
INTRADAY UPDATE
MARKETS
MOVERS
TRADING IDEAS
4/3/2024Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session